Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraarticular Infliximab for Refractory Knee Arthritis
NCT00521963Phase 3Withdrawn
- Sponsor
- Emek Medical Center
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in inflammatory arthritis, monoarthritis, sponsored by Emek Medical Center. Planned start Mar 2010; status: withdrawn.
02
Drugs
infliximab
03
Conditions
inflammatory arthritismonoarthritis
Beyond the preview
Go deeper on NCT00521963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521963.